Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. 

Health Care

Pharmaceutical

Aquestive Therapeutics

Aquestive Therapeutics' headquarters in Warren, NJ, United States

Daniel Barber

Sherry Korczynski

Matthew Davis

Peter Boyd

Ernie Toth

Mark Schobel

Lori J. Braender

Cassie Jung

Tim Morris

David Golden

Jay Lieberman

Carlos Camargo

Marco Taglietti

Gregory B. Brown

John Cochran

Julie Krop

Santo J. Costa

David M. Fleischer

David Bernstein

Matthew Greenhawt

Ruchi Gupta

John Oppenheimer

The Leadership Team at Aquestive Therapeutics is responsible for guiding the strategic direction of the company and overseeing the development and commercialization of specialty pharmaceutical products. Comprising key executives from various functions including operations, research and development, finance, and regulatory affairs, the team ensures alignment across departments to drive innovation and enhance the company's portfolio focused on central nervous system therapies. Through collaboration and expert oversight, the Leadership Team works to achieve the company’s mission of delivering effective treatments to patients.

Leadership Team

The Quality Assurance and Compliance team at Aquestive Therapeutics ensures that all operations and products meet stringent regulatory standards and internal quality benchmarks. This team is responsible for overseeing quality systems, pharmacovigilance, and compliance with DEA regulations, ensuring that the company’s CNS therapies are safe, effective, and compliant throughout their development and manufacturing processes. Their efforts are crucial in maintaining the integrity of the company’s products and fostering trust with stakeholders.

Quality Assurance and Compliance

The Clinical Operations and Development team at Aquestive Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials for CNS-related therapies. This team collaborates closely with cross-functional partners to ensure compliance with regulatory standards, optimize study protocols, and analyze data, ultimately driving the successful development of innovative treatments like Libervant and Sympazan. Their work is crucial in bridging the gap between preclinical research and clinical application, ensuring that promising therapies progress efficiently through the development pipeline.

Clinical Operations and Development

��

Aquestive Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Quality Assurance and Compliance

Clinical Operations and Development

Offices

��������

Aquestive Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Quality Assurance and Compliance

Clinical Operations and Development

Offices

Related companies

��